tm logo

Monitor this mark

View On USPTO

ELAPRASE
Live/Registered
REGISTERED AND RENEWED

on 12 Oct 2017

Last Applicant/ Owned by

SHIRE HUMAN GENETIC THERAPIES, INC.

300 Shire Way

Lexington

MA

02421

Serial Number

78709009 filed on 08th Sep 2005

Registration Number

3320424 registered on 23rd Oct 2007

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq.

c/o IP Services NYC

875 Third Avenue

New York NY 10022

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ELAPRASE

Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome

First Use Date in General

31st Jul 2006

First Use Date in Commerce

31st Jul 2006

Mark Details

Serial Number

No 78709009

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
01st Jul 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01st Jul 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
01st Jul 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01st Jul 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01st Jul 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
12th Oct 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12th Oct 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12th Oct 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12th Oct 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Sep 2017TEAS SECTION 8 & 9 RECEIVED